Liver and Biliary Pathology — MCQs

A 20-year-old woman presents with a 4-week history of dry mouth, fatigue, fever, and yellow sclerae. Physical examination shows mild jaundice and hepatomegaly. Serum total bilirubin is 3.3 mg/dL. Serologic markers for viral hepatitis are negative. The anti-mitochondrial antibody test is negative. A liver biopsy discloses parenchymal and periportal inflammatory cell infiltrates composed primarily of lymphocytes and plasma cells. The patient's signs and symptoms abate following 2 months of treatment with steroids. Which of the following is the most likely diagnosis?

Q20Easy

In which cause of jaundice is there no bilirubin excretion in urine?

Liver and Biliary Pathology Indian Medical PG Practice Questions and MCQs

Question 11: Which sensitive stain is used to demonstrate copper in Wilson's disease?

A. Timms sulfide (Correct Answer)
B. Rhodamine
C. Rubeanic acid
D. Trichrome stain

Explanation: **Explanation:** **Wilson’s Disease** is an autosomal recessive disorder characterized by the accumulation of copper in various tissues, primarily the liver and brain, due to mutations in the *ATP7B* gene [1]. **Why Timms Sulfide is the correct answer:** While several stains can detect copper, **Timms sulfide silver stain** is considered the **most sensitive** histochemical method. It can detect even minute amounts of copper and other heavy metals by converting them into metal sulfides, which are then visualized using silver enhancement. In the early stages of Wilson’s disease, copper is distributed cytoplasmically; Timms stain is superior for detecting this non-granular copper. **Analysis of Incorrect Options:** * **Rhodamine & Rubeanic acid:** These are the most **commonly used** stains in clinical practice. They identify copper-associated protein in lysosomes (granular copper). However, they are less sensitive than Timms sulfide and may yield false negatives in early stages or in cases of diffuse cytoplasmic distribution. * **Trichrome stain (Masson’s Trichrome):** This is used to assess the degree of **fibrosis and cirrhosis** in the liver. It stains collagen blue/green but does not detect copper. **High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard for Diagnosis:** Quantitative hepatic copper measurement (>250 μg/g dry weight) via liver biopsy. * **Kayser-Fleischer (KF) Rings:** Copper deposition in the **Descemet’s membrane** of the cornea [2]. * **Biochemical Markers:** Decreased serum ceruloplasmin, increased urinary copper excretion, and decreased total serum copper [2]. * **Morphology:** Early changes include steatosis (fatty liver) and Mallory-Denk bodies, eventually progressing to macronodular cirrhosis [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 855-856, 858. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 394-395.

Question 12: Microvesicular steatohepatosis is typically seen in which of the following conditions?

A. Diabetes mellitus
B. Reye syndrome (Correct Answer)
C. Lipodystrophy
D. Phosphorus intoxication

Explanation: **Explanation:** **Microvesicular steatosis** is characterized by the accumulation of tiny lipid droplets within the cytoplasm of hepatocytes that do not displace the nucleus [1]. This occurs due to severe impairment of mitochondrial fatty acid β-oxidation. **Why Reye Syndrome is Correct:** Reye syndrome is a classic example of microvesicular steatosis. It typically occurs in children following a viral illness (like Influenza or Varicella) treated with **Aspirin (salicylates)**. Salicylates act as mitochondrial toxins, leading to mitochondrial dysfunction, hepatic failure, and encephalopathy. On histology, the liver shows diffuse microvesicular fat without significant inflammation or necrosis. **Analysis of Incorrect Options:** * **Diabetes mellitus & Lipodystrophy:** These are associated with **Macrovesicular steatosis** (Non-Alcoholic Fatty Liver Disease) [2]. In these conditions, large fat globules displace the nucleus to the periphery [2]. * **Phosphorus intoxication:** Acute phosphorus poisoning typically causes **periportal (Zone 1) necrosis** and can lead to macrovesicular changes, but it is not the classic prototype for microvesicular steatosis. **High-Yield Clinical Pearls for NEET-PG:** * **Other causes of Microvesicular Steatosis:** Acute Fatty Liver of Pregnancy (AFLP), Valproate toxicity, and Tetracycline toxicity. * **Other causes of Macrovesicular Steatosis:** Alcoholism (most common), Obesity, and Malnutrition (Kwashiorkor) [3]. * **Reye Syndrome Hallmark:** Electron microscopy reveals "swollen, pleomorphic mitochondria." * **Aspirin Contraindication:** Never give aspirin to children with viral fevers to prevent Reye syndrome; use Paracetamol instead. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, p. 73. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 851-852. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, p. 848.

Question 13: Which types of collagen are accumulated in the space of Disse in liver cirrhosis?

A. Type I and Type IV
B. Type II and Type IV
C. Type I and Type III (Correct Answer)
D. Type II and Type III

Explanation: Explanation: In a healthy liver, the **space of Disse** (the area between hepatocytes and sinusoidal endothelial cells) contains a delicate framework of **Type IV collagen** (basement membrane type) and reticulin. This allows for the free exchange of nutrients and proteins between the blood and hepatocytes. In **liver cirrhosis**, chronic injury leads to the activation of **Hepatic Stellate Cells (Ito cells)** [1]. Once activated, these cells transform into myofibroblasts and shift their production from the normal Type IV collagen to "fibrillar" collagen, specifically **Type I and Type III** [1]. This process, known as **capillarization of the sinusoids**, creates a dense fibrous barrier that obstructs metabolic exchange, leading to portal hypertension and hepatocyte dysfunction [2]. **Analysis of Options:** * **Option C (Correct):** Type I and Type III are the primary fibrillar collagens deposited during fibrosis and cirrhosis. * **Options A & B (Incorrect):** Type IV is a normal constituent of the space of Disse; its replacement by Type I/III is the hallmark of pathology. Type II collagen is primarily found in **hyaline cartilage** and is not involved in liver fibrosis. * **Option D (Incorrect):** While Type III is correct, Type II is not found in the liver. **High-Yield Clinical Pearls for NEET-PG:** * **Key Cell:** The **Hepatic Stellate Cell (Ito Cell)** is the primary source of excess collagen in cirrhosis [1]. * **Vitamin A:** In their quiescent state, Stellate cells are the body's main storage site for Vitamin A. * **Morphology:** The shift from Type IV to Type I/III collagen leads to the loss of endothelial fenestrations (capillarization). * **Stain:** **Masson’s Trichrome** is used to highlight these collagen fibers (stains blue). **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 381-382. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. With Illustrations By, pp. 32-34.

Question 14: Which of the following is NOT true about Focal Nodular Hyperplasia (FNH) of the liver?

A. It is an unusual benign tumor of the liver.
B. It is commonly symptomatic and occurs as multiple liver nodules. (Correct Answer)
C. It is more common in females than in males.
D. It contains hepatocytes and Kupffer cells.

Explanation: **Explanation:** **Focal Nodular Hyperplasia (FNH)** is the second most common benign liver tumor after hemangioma [1]. It is not a true neoplasm but rather a **hyperplastic response** of hepatocytes to a pre-existing localized vascular malformation. **Why Option B is the Correct Answer (The False Statement):** FNH is typically **asymptomatic** and is usually discovered incidentally during imaging or surgery for unrelated reasons. Furthermore, it most commonly presents as a **solitary, well-circumscribed nodule** (80-95% of cases) rather than multiple nodules. Pain or symptoms only occur if the lesion is exceptionally large. **Analysis of Other Options:** * **Option A:** It is indeed an **unusual benign tumor** (technically a tumor-like condition) characterized by a "spoke-wheel" appearance on imaging. * **Option C:** There is a strong female predilection (F:M ratio approx. 8:1), typically occurring in the 3rd to 5th decades of life. Unlike hepatic adenomas, its link to oral contraceptives is controversial and less definitive. * **Option D:** Histologically, FNH contains all normal liver constituents—**hepatocytes, Kupffer cells, and bile ducts**—but they are organized abnormally. The presence of Kupffer cells allows FNH to take up Technetium-99m sulfur colloid on scintigraphy, a key diagnostic feature. **NEET-PG High-Yield Pearls:** * **Pathognomonic Feature:** A **central stellate scar** containing large thick-walled arteries. * **Imaging:** "Spoke-wheel" vascularity on angiography. * **Management:** Usually conservative (observation) as there is **no risk of malignant transformation** or spontaneous hemorrhage (unlike Hepatic Adenoma). * **Microscopy:** Shows "ductular reaction" at the edge of the fibrous septa. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 398-399.

Question 15: Which one of the following diseases characteristically causes fatty change in the liver?

A. Hepatitis B virus infection
B. Wilson's disease
C. Hepatitis C virus infection
D. Chronic alcoholism (Correct Answer)

Explanation: **Explanation:** **Chronic Alcoholism (Correct Answer):** Alcoholic Liver Disease (ALD) is the most common cause of macrovesicular steatosis (fatty change) [1]. The underlying mechanism involves an increased NADH/NAD+ ratio generated by alcohol dehydrogenase [3]. This biochemical shift inhibits fatty acid oxidation (beta-oxidation) and stimulates lipogenesis. Additionally, alcohol increases the peripheral mobilization of fatty acids and decreases the secretion of VLDL, leading to the accumulation of triglycerides within hepatocytes. **Analysis of Incorrect Options:** * **Hepatitis B Virus (HBV):** Characteristically presents with **"Ground-glass hepatocytes"** due to the accumulation of HBsAg in the endoplasmic reticulum [4]. It does not typically cause fatty change. * **Wilson’s Disease:** While it can cause steatosis in early stages, its hallmark is the accumulation of copper, leading to **Kayser-Fleischer rings** and cirrhosis [4]. It is less "characteristic" for fatty change compared to alcohol. * **Hepatitis C Virus (HCV):** Genotype 3 is known to cause steatosis, but the classic histological finding for HCV is **lymphoid aggregates** in the portal tracts and bile duct damage [4]. **NEET-PG High-Yield Pearls:** * **Microvesicular Steatosis:** Seen in Reye’s syndrome, Fatty liver of pregnancy, and Sodium Valproate toxicity. * **Macrovesicular Steatosis:** Seen in Alcoholism, Obesity, and Diabetes Mellitus (NAFLD) [2]. * **Mallory-Denk Bodies:** Eosinophilic cytoplasmic inclusions (cytokeratin intermediate filaments) seen in Alcoholic Hepatitis, Wilson’s disease, and Alpha-1 antitrypsin deficiency [4]. * **Reversibility:** Fatty change (steatosis) is the earliest and fully reversible stage of alcoholic liver disease [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 848-850. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 389-390. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, p. 848. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 388-389.

Question 16: Which of the following conditions is characterized by macronodular cirrhosis?

A. Primary biliary cirrhosis
B. Indian childhood cirrhosis
C. Hemochromatosis
D. Wilson's disease (Correct Answer)

Explanation: Cirrhosis is morphologically classified based on nodule size: **Micronodular** (<3 mm, uniform nodules) and **Macronodular** (>3 mm, varying sizes) [1]. **Why Wilson’s Disease is Correct:** Wilson’s disease (hepatolenticular degeneration) is a disorder of copper metabolism [1]. While it may initially present with micronodular changes, it characteristically progresses to **macronodular cirrhosis** (post-necrotic type) as the disease advances [1]. The toxic accumulation of copper leads to large areas of parenchymal collapse and subsequent coarse regeneration, forming large nodules [2]. **Analysis of Incorrect Options:** * **A. Primary Biliary Cirrhosis (PBC):** This is an autoimmune destruction of intrahepatic bile ducts [1]. It typically results in **micronodular cirrhosis** because the cholestatic injury is diffuse and uniform across the liver lobules. * **B. Indian Childhood Cirrhosis (ICC):** Characterized by massive copper deposition and "creeping" fibrosis, ICC typically presents with **micronodular cirrhosis** and a lack of regenerative nodules (due to the severity of the insult). * **C. Hemochromatosis:** Iron overload causes diffuse, fine scarring throughout the liver, leading to a classic **micronodular** pattern (often described as a "brick-red" liver) [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Macronodular causes:** Chronic Viral Hepatitis (B and C) and Wilson’s disease. * **Micronodular causes:** Alcohol (most common), Hemochromatosis, and Biliary cirrhosis [1]. * **Wilson’s Disease Triad:** Liver cirrhosis, Basal ganglia symptoms (Parkinsonism), and Kayser-Fleischer (KF) rings in the cornea [1]. * **Diagnostic Gold Standard:** Increased hepatic copper content (>250 μg/g dry weight). **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 388-396. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 855-856.

Question 17: Florid duct lesions are diagnostic of which of the following conditions?

A. Klatskin tumor
B. Primary sclerosing cholangitis
C. Primary biliary cirrhosis (Correct Answer)
D. Secondary biliary cirrhosis

Explanation: **Explanation:** **Primary Biliary Cholangitis (formerly Primary Biliary Cirrhosis - PBC)** is characterized by the chronic, progressive destruction of small-to-medium-sized intrahepatic bile ducts. The hallmark histopathological finding is the **Florid Duct Lesion** [1]. This lesion consists of a heavy inflammatory infiltrate (lymphocytes and plasma cells) surrounding a bile duct, often associated with **non-caseating granulomatous destruction** of the ductal epithelium [1]. **Analysis of Options:** * **Primary Biliary Cholangitis (PBC):** Correct. It is an autoimmune condition primarily affecting middle-aged women. The "Florid Duct Lesion" is the diagnostic morphological feature seen in Stage I of the disease [1]. * **Primary Sclerosing Cholangitis (PSC):** Incorrect. PSC involves both intra- and extrahepatic ducts. Its characteristic histopathology is **"Onion-skin fibrosis"** (periductal concentric fibrosis), not florid duct lesions. * **Klatskin Tumor:** Incorrect. This is a hilar cholangiocarcinoma occurring at the junction of the right and left hepatic ducts. It presents as a malignant glandular neoplasm. * **Secondary Biliary Cirrhosis:** Incorrect. This results from prolonged mechanical obstruction of the extrahepatic biliary tree (e.g., gallstones or strictures). It is characterized by bile stasis, bile lakes, and ductular proliferation, but lacks the specific autoimmune granulomatous lesions of PBC. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for PBC:** The **"4 Ms"** — **M**iddle-aged **M**others, **M**itochondrial antibodies (AMA positive in 95%), and **M**IgM elevation. * **Associated Conditions:** PBC is frequently associated with other autoimmune diseases like Sjögren’s syndrome and Hashimoto’s thyroiditis. * **Biochemical Marker:** Markedly elevated **Alkaline Phosphatase (ALP)** and GGT. * **Treatment:** Ursodeoxycholic acid (UDCA) is the first-line medical management. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 864-865.

Question 18: Which of the following benign tumors is associated with the prolonged use of oral contraceptive pills?

A. Hepatic adenoma (Correct Answer)
B. Thyroid adenoma
C. Fibroadenoma
D. Myoma

Explanation: **Explanation:** **Hepatic Adenoma (Correct Answer):** Hepatic adenoma is a benign epithelial liver tumor strongly associated with the prolonged use of **oral contraceptive pills (OCPs)** [1], [2]. The risk increases significantly with the duration of use and the estrogen dose [1]. These tumors are often subcapsular and carry a clinical risk of **spontaneous rupture and life-threatening intraperitoneal hemorrhage**, especially during pregnancy. Histologically, they consist of sheets of hepatocytes without normal lobular architecture (absence of portal tracts). **Incorrect Options:** * **Thyroid Adenoma:** These are benign follicular neoplasms of the thyroid gland. Their pathogenesis is primarily linked to TSH receptor mutations or iodine deficiency, not OCP use. * **Fibroadenoma:** This is the most common benign tumor of the female breast. While estrogen-sensitive (they may enlarge during pregnancy), they are not classically linked to OCP use as a primary causative factor in the same definitive manner as hepatic adenomas. * **Myoma (Leiomyoma):** These are benign smooth muscle tumors of the uterus. While their growth is estrogen-dependent, they are not "caused" by OCPs; in fact, OCPs are often used as a treatment modality to manage the heavy bleeding associated with them. **High-Yield Clinical Pearls for NEET-PG:** * **Molecular Subtypes:** The **HNF1-α inactivated** subtype [1] has the lowest risk of malignancy, while the **β-catenin activated** subtype has the highest risk of malignant transformation to Hepatocellular Carcinoma (HCC). * **Management:** Discontinuation of OCPs can lead to the regression of the tumor [1]. * **Imaging:** On imaging, they may show a "steatotic" appearance (HNF1-α type) or "atypical" enhancement. * **Anabolic Steroids:** Besides OCPs, the use of anabolic steroids is another significant risk factor for hepatic adenomas [1], [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, p. 874. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Infectious Diseases, pp. 429-430.

Question 19: A 20-year-old woman presents with a 4-week history of dry mouth, fatigue, fever, and yellow sclerae. Physical examination shows mild jaundice and hepatomegaly. Serum total bilirubin is 3.3 mg/dL. Serologic markers for viral hepatitis are negative. The anti-mitochondrial antibody test is negative. A liver biopsy discloses parenchymal and periportal inflammatory cell infiltrates composed primarily of lymphocytes and plasma cells. The patient's signs and symptoms abate following 2 months of treatment with steroids. Which of the following is the most likely diagnosis?

A. Autoimmune hepatitis (Correct Answer)
B. Extrahepatic jaundice
C. Primary biliary cirrhosis
D. Primary sclerosing cholangitis

Explanation: **Explanation:** The clinical presentation and histopathology point directly to **Autoimmune Hepatitis (AIH)**. [1] **1. Why Autoimmune Hepatitis is correct:** * **Demographics:** AIH typically affects young to middle-aged women (as seen in this 20-year-old patient). * **Histopathology:** The hallmark of AIH is **"Interface Hepatitis"** (periportal inflammation) characterized by a dense infiltrate of **lymphocytes and plasma cells**. [1] The presence of plasma cells is a high-yield diagnostic clue. * **Treatment Response:** AIH is highly responsive to **corticosteroids** (prednisolone) or immunosuppressants (azathioprine), which aligns with the patient’s recovery. * **Serology:** Negative viral markers and negative Anti-Mitochondrial Antibodies (AMA) rule out common differentials. [1] **2. Why other options are incorrect:** * **Extrahepatic Jaundice:** This is a mechanical obstruction (e.g., gallstones). It presents with conjugated hyperbilirubinemia and dilated bile ducts on ultrasound, not plasma cell-rich parenchymal inflammation. * **Primary Biliary Cholangitis (PBC):** While it affects women, it is characterized by **positive AMA** (95% of cases) and the destruction of small intrahepatic bile ducts (florid duct lesions), rather than diffuse interface hepatitis. [1] * **Primary Sclerosing Cholangitis (PSC):** This typically affects males and is strongly associated with Ulcerative Colitis. Histology shows **"onion-skin" fibrosis** of the bile ducts. **High-Yield Clinical Pearls for NEET-PG:** * **Type 1 AIH:** Most common; associated with **ANA** (Anti-Nuclear Antibody) and **ASMA** (Anti-Smooth Muscle Antibody). [1] * **Type 2 AIH:** More common in children/adolescents; associated with **Anti-LKM1** (Liver Kidney Microsome type 1) antibodies. [1] * **Diagnostic Clue:** If a question mentions "Plasma cells in liver biopsy" + "Response to steroids," always think Autoimmune Hepatitis. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 845-846.

Question 20: In which cause of jaundice is there no bilirubin excretion in urine?

A. Obstructive jaundice
B. Primary biliary cirrhosis
C. Extrahepatic biliary atresia
D. Hemolytic jaundice (Correct Answer)

Explanation: **Explanation:** The presence or absence of bilirubin in urine depends on whether the bilirubin is **conjugated** or **unconjugated** [2], [3]. **1. Why Hemolytic Jaundice is correct:** In hemolytic jaundice, there is an overproduction of bilirubin due to the excessive breakdown of red blood cells [1]. This results in high levels of **unconjugated (indirect) bilirubin**. Unconjugated bilirubin is tightly bound to albumin, making it water-insoluble; therefore, it cannot be filtered by the renal glomeruli and does not appear in the urine [2], [5]. This is why hemolytic jaundice is often referred to as **"acholuric jaundice"** (jaundice without bilirubinuria). **2. Why the other options are incorrect:** * **Obstructive Jaundice (A), Primary Biliary Cirrhosis (B), and Extrahepatic Biliary Atresia (C):** All three conditions involve cholestasis (obstruction to bile flow). In these cases, the liver successfully conjugates the bilirubin, but it cannot be excreted into the intestine [4]. This **conjugated (direct) bilirubin** regurgitates into the bloodstream. Because conjugated bilirubin is water-soluble and not bound to albumin, it is easily filtered by the kidneys, leading to dark-colored urine (bilirubinuria) [3], [5]. **High-Yield NEET-PG Pearls:** * **Urine Bilirubin:** Only conjugated bilirubin appears in urine [5]. * **Urine Urobilinogen:** Increased in hemolytic jaundice; absent in complete obstructive jaundice (clay-colored stools) [1], [4]. * **Van den Bergh Reaction:** Indirect positive in hemolytic jaundice; Direct positive in obstructive jaundice; Biphasic in hepatocellular jaundice. * **Key Concept:** If a patient is jaundiced but the urine dipstick is negative for bilirubin, think **Hemolysis** or **Gilbert Syndrome**. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, p. 640. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 858-860. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 380-381. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 385-386. [5] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 384-385.

Practice by Chapter

Jaundice and Cholestasis

Practice Questions

Viral Hepatitis

Practice Questions

Alcoholic and Non-alcoholic Fatty Liver Disease

Practice Questions

Drug and Toxin Induced Liver Injury

Practice Questions

Cirrhosis and Its Complications

Practice Questions

Metabolic Liver Diseases

Practice Questions

Liver Tumors

Practice Questions

Gallbladder and Biliary Tract Diseases

Practice Questions

Congenital Liver Diseases

Practice Questions

Liver Transplantation Pathology

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free